149 related articles for article (PubMed ID: 16688744)
1. Pancreatic adenocarcinoma -- genetic portrait from chromosomes to microarrays.
Karhu R; Mahlamäki E; Kallioniemi A
Genes Chromosomes Cancer; 2006 Aug; 45(8):721-30. PubMed ID: 16688744
[TBL] [Abstract][Full Text] [Related]
2. Genome-wide aberrations in pancreatic adenocarcinoma.
Nowak NJ; Gaile D; Conroy JM; McQuaid D; Cowell J; Carter R; Goggins MG; Hruban RH; Maitra A
Cancer Genet Cytogenet; 2005 Aug; 161(1):36-50. PubMed ID: 16080956
[TBL] [Abstract][Full Text] [Related]
3. CGH microarrays and cancer.
Kallioniemi A
Curr Opin Biotechnol; 2008 Feb; 19(1):36-40. PubMed ID: 18162393
[TBL] [Abstract][Full Text] [Related]
4. Gene expression profiling and gene copy-number changes in malignant mesothelioma cell lines.
Zanazzi C; Hersmus R; Veltman IM; Gillis AJ; van Drunen E; Beverloo HB; Hegmans JP; Verweij M; Lambrecht BN; Oosterhuis JW; Looijenga LH
Genes Chromosomes Cancer; 2007 Oct; 46(10):895-908. PubMed ID: 17620293
[TBL] [Abstract][Full Text] [Related]
5. Combined array-comparative genomic hybridization and single-nucleotide polymorphism-loss of heterozygosity analysis reveals complex genetic alterations in cervical cancer.
Kloth JN; Oosting J; van Wezel T; Szuhai K; Knijnenburg J; Gorter A; Kenter GG; Fleuren GJ; Jordanova ES
BMC Genomics; 2007 Feb; 8():53. PubMed ID: 17311676
[TBL] [Abstract][Full Text] [Related]
6. Integrated analysis of expression and genome alteration reveals putative amplified target genes in esophageal cancer.
Sugimoto T; Arai M; Shimada H; Hata A; Seki N
Oncol Rep; 2007 Aug; 18(2):465-72. PubMed ID: 17611672
[TBL] [Abstract][Full Text] [Related]
7. Combined gene expression analysis of whole-tissue and microdissected pancreatic ductal adenocarcinoma identifies genes specifically overexpressed in tumor epithelia.
Badea L; Herlea V; Dima SO; Dumitrascu T; Popescu I
Hepatogastroenterology; 2008; 55(88):2016-27. PubMed ID: 19260470
[TBL] [Abstract][Full Text] [Related]
8. Identification of genes involved in squamous cell carcinoma of the lung using synchronized data from DNA copy number and transcript expression profiling analysis.
Lo KC; Stein LC; Panzarella JA; Cowell JK; Hawthorn L
Lung Cancer; 2008 Mar; 59(3):315-31. PubMed ID: 18029052
[TBL] [Abstract][Full Text] [Related]
9. Molecular cytogenetic characterization of pancreas cancer cell lines reveals high complexity chromosomal alterations.
Griffin CA; Morsberger L; Hawkins AL; Haddadin M; Patel A; Ried T; Schrock E; Perlman EJ; Jaffee E
Cytogenet Genome Res; 2007; 118(2-4):148-56. PubMed ID: 18000365
[TBL] [Abstract][Full Text] [Related]
10. [Construction and primary application of oligonucleotide microarray specialized for pancreatic adenocarcinoma-associated genes].
Shi X; Wei WJ; Gao NR; Cheng ZJ; Tang YH
Zhonghua Wai Ke Za Zhi; 2007 Jan; 45(1):39-42. PubMed ID: 17403288
[TBL] [Abstract][Full Text] [Related]
11. Frequent occurrence of uniparental disomy in colorectal cancer.
Andersen CL; Wiuf C; Kruhøffer M; Korsgaard M; Laurberg S; Ørntoft TF
Carcinogenesis; 2007 Jan; 28(1):38-48. PubMed ID: 16774939
[TBL] [Abstract][Full Text] [Related]
12. The genetics of pancreatic adenocarcinoma: a roadmap for a mouse model.
Bardeesy N; Sharpless NE; DePinho RA; Merlino G
Semin Cancer Biol; 2001 Jun; 11(3):201-18. PubMed ID: 11407945
[TBL] [Abstract][Full Text] [Related]
13. Molecular genetic basis of pancreatic adenocarcinoma.
Hilgers W; Kern SE
Genes Chromosomes Cancer; 1999 Sep; 26(1):1-12. PubMed ID: 10440999
[TBL] [Abstract][Full Text] [Related]
14. The role of epigenetic alterations in pancreatic cancer.
Sato N; Goggins M
J Hepatobiliary Pancreat Surg; 2006; 13(4):286-95. PubMed ID: 16858539
[TBL] [Abstract][Full Text] [Related]
15. Expression analysis of pancreatic cancer cell lines reveals association of enhanced gene transcription and genomic amplifications at the 8q22.1 and 8q24.22 loci.
Domagk D; Schaefer KL; Eisenacher M; Braun Y; Wai DH; Schleicher C; Diallo-Danebrock R; Bojar H; Roeder G; Gabbert HE; Domschke W; Poremba C
Oncol Rep; 2007 Feb; 17(2):399-407. PubMed ID: 17203180
[TBL] [Abstract][Full Text] [Related]
16. Molecular pathogenesis of pancreatic adenocarcinoma: potential clinical implications.
Talar-Wojnarowska R; Malecka-Panas E
Med Sci Monit; 2006 Sep; 12(9):RA186-93. PubMed ID: 16940943
[TBL] [Abstract][Full Text] [Related]
17. High-resolution characterization of the pancreatic adenocarcinoma genome.
Aguirre AJ; Brennan C; Bailey G; Sinha R; Feng B; Leo C; Zhang Y; Zhang J; Gans JD; Bardeesy N; Cauwels C; Cordon-Cardo C; Redston MS; DePinho RA; Chin L
Proc Natl Acad Sci U S A; 2004 Jun; 101(24):9067-72. PubMed ID: 15199222
[TBL] [Abstract][Full Text] [Related]
18. Intersex-like (IXL) is a cell survival regulator in pancreatic cancer with 19q13 amplification.
Kuuselo R; Savinainen K; Azorsa DO; Basu GD; Karhu R; Tuzmen S; Mousses S; Kallioniemi A
Cancer Res; 2007 Mar; 67(5):1943-9. PubMed ID: 17332321
[TBL] [Abstract][Full Text] [Related]
19. DNA array/microarrays in oncological research with focus on pancreatic cancer.
Baron A; Moore PS; Scarpa A
Adv Clin Path; 2001 Oct; 5(4):115-20. PubMed ID: 17582935
[TBL] [Abstract][Full Text] [Related]
20. Array comparative genomic hybridization analysis of chromosomal imbalances and their target genes in gastrointestinal stromal tumors.
Assämäki R; Sarlomo-Rikala M; Lopez-Guerrero JA; Lasota J; Andersson LC; Llombart-Bosch A; Miettinen M; Knuutila S
Genes Chromosomes Cancer; 2007 Jun; 46(6):564-76. PubMed ID: 17330260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
